Research News

Tumor Therapy of the Future - An interdisciplinary team of chemists, biochemists, geneticists and molecular biologists at UZH, three of them CRC members - Christian Mosimann, Amedeo Caflish and Tuncay Baubec together with Cristina Nevado, have been awarded a SNSF Sinergia grant (3.2 Million CHF).

Tumor Therapy of the Future

An interdisciplinary team of chemists, biochemists, geneticists and molecular biologists at UZH, three of them CRC members - Christian Mosimann, Amedeo Caflish and Tuncay Baubec together with Cristina Nevado, have been awarded a SNSF Sinergia grant (3.2 Million CHF).This collaboration will enable research into new epigenetic approaches for treating Acute Myeloid Leukemia (AML), a dangerous cancer of the blood cells. Together they’re addressing the question of how certain enzymes switch genes in the chromosome on and off. MORE